BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17084656)

  • 1. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
    Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
    Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis.
    Alfonso P; Núñez A; Madoz-Gurpide J; Lombardia L; Sánchez L; Casal JI
    Proteomics; 2005 Jul; 5(10):2602-11. PubMed ID: 15924290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of protein expression in human tonsillar cancer: differentially expressed proteins characterize human tonsillar cancer.
    Roblick UJ; Bader FG; Hammarstedt L; Habermann JK; Hellman U; Becker S; Sundmacker A; Gemoll T; Zimmermann K; Auer G; Munck-Wikland E
    Acta Oncol; 2008; 47(8):1493-501. PubMed ID: 18759147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia.
    Polley AC; Mulholland F; Pin C; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Res; 2006 Jul; 66(13):6553-62. PubMed ID: 16818627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin.
    Xing X; Lai M; Gartner W; Xu E; Huang Q; Li H; Chen G
    Proteomics; 2006 May; 6(9):2916-23. PubMed ID: 16586428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
    Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer.
    Petrova DT; Asif AR; Armstrong VW; Dimova I; Toshev S; Yaramov N; Oellerich M; Toncheva D
    Clin Biochem; 2008 Oct; 41(14-15):1224-36. PubMed ID: 18710659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials.
    Liang L; Qu L; Ding Y
    Cancer Invest; 2007 Sep; 25(6):427-34. PubMed ID: 17882654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.
    Alfonso P; Cañamero M; Fernández-Carbonié F; Núñez A; Casal JI
    J Proteome Res; 2008 Oct; 7(10):4247-55. PubMed ID: 18707159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of protein expression maps of two metastatic colorectal carcinoma cell lines generated by two-dimensional gel electrophoresis].
    Liang L; Ding YQ; Li X; Jiang PZ; Li XH; Zhang JH
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):18-21. PubMed ID: 15683989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry.
    Melle C; Osterloh D; Ernst G; Schimmel B; Bleul A; von Eggeling F
    Int J Mol Med; 2005 Jul; 16(1):11-7. PubMed ID: 15942672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers.
    Liu S; Sun MZ; Tang JW; Wang Z; Sun C; Greenaway FT
    Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3172-8. PubMed ID: 18798201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteome study of colorectal cancer genesis and hepatic metastasis].
    Bai X; Li SY; An P; Yu B; Cai HY
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2128-31. PubMed ID: 16313824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular protein alterations in colorectal cancer: p28, p53 and p65 studies.
    Stawińska M; Bryś M; Kiliańska ZM; Hanausek-Wataszek M; Krajewska WM
    Cytobios; 2001; 106 Suppl 1():43-55. PubMed ID: 11534828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer.
    Kovarova H; Stulík J; Hochstrasser DF; Bures J; Melichar B; Jandík P
    Appl Theor Electrophor; 1994; 4(3):103-6. PubMed ID: 7612691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.